{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05839210",
            "orgStudyIdInfo": {
                "id": "20221298"
            },
            "organization": {
                "fullName": "University of Miami",
                "class": "OTHER"
            },
            "briefTitle": "Lifestyle Intervention of Food and Exercise for Lymphoma Survivors",
            "officialTitle": "Lifestyle Intervention of Food and Exercise for Lymphoma Survivors (LIFE - L)",
            "acronym": "LIFE-L",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "lifestyle-intervention-of-food-and-exercise-for-lymphoma-survivors"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-04-26",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-04-26",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-04-26",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-03-31",
            "studyFirstSubmitQcDate": "2023-04-19",
            "studyFirstPostDateStruct": {
                "date": "2023-05-03",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-24",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-25",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Tracy E Crane, PhD, RDN",
                "investigatorTitle": "Associate Professor",
                "investigatorAffiliation": "University of Miami"
            },
            "leadSponsor": {
                "name": "University of Miami",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to investigate if a mediterranean diet and exercise program for Lymphoma patients during chemotherapy can improve treatment completion and reduce treatment-related side effects."
        },
        "conditionsModule": {
            "conditions": [
                "Non Hodgkin Lymphoma",
                "Hodgkin Lymphoma"
            ],
            "keywords": [
                "Mediterranean Diet",
                "Exercise Program"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "OTHER",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 120,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "LIFE-L Group",
                    "type": "EXPERIMENTAL",
                    "description": "Participants already undergoing chemotherapy treatment as per standard of care for 6 cycles will meet weekly via phone for 30-45 minutes with a health coach that will provide education on a Mediterranean diet and an exercise program.",
                    "interventionNames": [
                        "Behavioral: LIFE-L Mediterranean Diet",
                        "Behavioral: LIFE-L Home-Based Exercise Program",
                        "Behavioral: Supportive Materials"
                    ]
                },
                {
                    "label": "Control Group",
                    "type": "OTHER",
                    "description": "Participants in this group already undergoing 6 cycles of chemotherapy will receive study materials and two 30-45 minutes health coaching sessions four weeks post- intervention.",
                    "interventionNames": [
                        "Behavioral: Supportive Materials"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "LIFE-L Mediterranean Diet",
                    "description": "Mediterranean Diet will include goals of: 4+ vegetable servings (2-4 cups) daily, 2+ fruit servings (1.5-2 cups) daily, 2+ whole grain servings daily, 1+ legume serving daily, 1+ serving nuts and seeds daily, and seafood 2 times per week. Limit or avoid highly processed foods, sugar-sweetened beverages and foods, processed meats, red meat, and alcohol.",
                    "armGroupLabels": [
                        "LIFE-L Group"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "LIFE-L Home-Based Exercise Program",
                    "description": "The Home-Based Exercise Program will include goals of: 150+ minutes moderate or 75+ minutes vigorous exercise per week, completed in sessions of at least 10-minute duration, including daily aerobic exercise plus two resistance-based exercise sessions per week.",
                    "armGroupLabels": [
                        "LIFE-L Group"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Supportive Materials",
                    "description": "Participants will receive an informational study notebook, an exercise reference poster and videos, a Fitbit, and three stretch bands of different intensities. Participants will also receive supportive and informational text messages or emails three (3) times per week during the study; participants can opt-out of these messages.\n\nParticipants will be requested to utilize the Fitbit app to track exercise sessions, as well as the MyFitnessPal app to track their diet. Support to set up apps will be provided by research staff. For participants who choose not to use the app, a laminated diet and exercise tracking sheet with dry erase marker will be provided, and participants will be advised to send a picture of their completed tracking sheet by text message to research staff each week.",
                    "armGroupLabels": [
                        "Control Group",
                        "LIFE-L Group"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Percentage of Survivors who participate",
                    "description": "Percentage of survivors who agree to participate out of the total number of participants recruited will be assessed using a threshold of greater than or equal to (\\>=) 50-percent.",
                    "timeFrame": "Up to 12 months"
                },
                {
                    "measure": "Percentage of Participants Completing Intervention Sessions",
                    "description": "Percentage of intervention session completion at the end of treatment will be assessed, using a threshold of greater than or equal to (\\>=) 80-percent.",
                    "timeFrame": "Up to 26 weeks (Post-Intervention)"
                },
                {
                    "measure": "Change in percentage of participant satisfaction",
                    "description": "The change in percentage of participant satisfaction rate at the end of study participation will be assessed, using a threshold of greater than or equal to (\\>=) 80-percent. Participant satisfaction will be assessed via exit interviews.",
                    "timeFrame": "4 weeks (post-intervention), up to 30 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Average Relative Dose Intensity (RDI)",
                    "description": "RDI will be assessed using a threshold of greater than or equal to (\\>=) 80-percent.",
                    "timeFrame": "Up to 30 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. 18 years of age or older\n2. Any sex/gender\n3. Able to provide consent\n4. Able to read or understand English or Spanish\n5. Diagnosis of untreated Non-Hodgkin or Hodgkin lymphoma, requiring at least 6 cycles of chemotherapy, being treated with one of the following therapies at discretion of PIs:\n\n   1. R-CHOP or R-CHOP-like regimen\n   2. BR\n   3. BV-AVD or ABVD or checkpoint inhibitor+AVD\n6. ECOG Performance Status grade of \\<2\n\n   a. PI approval needed if ECOG = 2\n7. Approval from treating oncologist, confirmed via email or in writing\n8. Delivery of chemotherapy treatments at one of the following institutions:\n\n   1. Sylvester Comprehensive Cancer Center (including satellite/network sites)\n   2. University of Miami Hospital/UHealth Tower\n9. Internet access on a smart phone, tablet, or computer\n10. Willing to be randomized to a Mediterranean diet/home-based physical activity intervention or waitlist-control group.\n\nExclusion Criteria:\n\n1. Individuals younger than 18 years of age\n2. Unable to provide consent\n3. Unable to read or understand English or Spanish\n4. Any contraindication for diet change or exercising as determined by physician\n5. Currently following a vegan or ketogenic diet, or consuming more than 5 servings of fruit and vegetables per day for the prior month\n6. Engaging in \\>150 minutes of moderate to vigorous physical activity on average per week for the prior month\n7. History of dementia or major psychiatric disease\n8. History of recent (\u22641 yr) stroke, myocardial infarction or congestive heart failure",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Tracy E Crane, PhD, RDN",
                    "role": "CONTACT",
                    "phone": "305-243-8255",
                    "email": "tecrane@med.miami.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Tracy E Crane, Phd, RDN",
                    "affiliation": "University of Miami",
                    "role": "PRINCIPAL_INVESTIGATOR"
                },
                {
                    "name": "Craig Moskowitz, MD",
                    "affiliation": "University of Miami",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Miami",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33136",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Tracy E Crane, PhD, RDN",
                            "role": "CONTACT",
                            "phone": "305-243-8255",
                            "email": "tecrane@med.miami.edu"
                        },
                        {
                            "name": "Tracy E Crane, PhD, RDN",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Craig Moskowitz, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008223",
                    "term": "Lymphoma"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000008232",
                    "term": "Lymphoproliferative Disorders"
                },
                {
                    "id": "D000008206",
                    "term": "Lymphatic Diseases"
                },
                {
                    "id": "D000007160",
                    "term": "Immunoproliferative Disorders"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11220",
                    "name": "Lymphoma",
                    "asFound": "Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9751",
                    "name": "Hodgkin Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M11225",
                    "name": "Lymphoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11203",
                    "name": "Lymphatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10206",
                    "name": "Immunoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T3543",
                    "name": "Lymphosarcoma",
                    "asFound": "Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2817",
                    "name": "Hodgkin Lymphoma",
                    "asFound": "Hodgkin Lymphoma",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M3777",
                    "name": "Ethanol",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}